← Eichor
Study identifier: NCT07248267 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down Syndrome

Condition: Down Syndrome  ·  Sponsor: Riphah International University

PhaseNA
Planned participants28
Who can joinAll sexes, 2 Years to 10 Years
Healthy volunteersYes

About this study

This randomized clinical trial investigates the effects of Vojta therapy on functional mobility and gait parameters in children with down syndrome. The study involves 28 male and female children aged 2-10 years old, who will be randomly assigned to one of the two groups i.e. control and experimental group. Key performance outcomes -GMFM 88 and gait outcome assessment -will be assessed both before and after the intervention. The research aims to evaluate the effects of vojta therapy on functional mobility and gait parameters in children with down syndrome. This RCT study will examine the potential key parameters of gait I.e. its spacial parameters that are step length, stride length, stride width, In and out toe and BOS and functional mobility Data will be analyzed through SPSS version 27.00.

This description comes directly from the study's public registry record.

Talk to the study team

IMRAN AMJAD, PhD  ·  9233224390125  ·  imran.amjad@riphah.edu.pk

Muhammad Asif Javed, MS-PT  ·  923224209422  ·  a.javed@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

HashimLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07248267